Myocarditis and the smallpox vaccine
how vaccine surveillance is supposed to be done. From 2015
At this point, it is nearly a daily occurrence that new data appears, showing high rates of adverse effects from mRNA vaccines. Alex Berenson writes about Iceland data today, showing an increased rate of death in young persons after mRNA vaccination. Last week was the impressive prospective study from Thailand, showing 29% case of abnormal cardiac tests after mRNA vaccines.
This material calls forth a certain amount of anguish, since the initial covid vaccine studies were amply large enough to have detected heart or mortality problems. Their failure to do so is a problem all of its own, implying the possibility of fraud or else gross incompetence in study design/evaluation. We will wait in suspense for a few more months, until the full release of Pfizer’s study data and its forensic analysis.
Meanwhile, The Hart Group has here described a well-executed study from 2015, wherein active surveillance of smallpox vaccination in US military members found an extremely high rate of myocarditis. The US military discontinued smallpox vaccination, perhaps due to this study. However, what it shows is how to properly set up a surveillance/safety campaign for a new vaccine. This is the same type of approach that the Thailand study took. It is an obvious design: check your patients’ hearts before you inject them, then check them again afterwards.
Why didn’t we do this for the covid vaccines?
Thank you. I am actually the author of the HART article. Unfortunately due to vacations it was published a few weeks later than I'd hoped, during which time of course the Thailand study was published, doing exactly what I had called for. Anyway, many have now commented on the Thailand study, which (notably) found a very similar rate of subclinical myocarditis (2-3%). I may do a briefing on it although nearly everything that needs to be said about it has already been written. Regards.
The Thai paper got published! No longer a mere preprint!